Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Plos One|June 27, 2019
Virome capture sequencing does not identify active viral infection in unicentric and idiopathic multicentric Castleman diseaseChristopher S Nabel, Stephen Sameroff, Dustin Shilling, et al.
Genome Biology|July 5, 2012
A tool kit for quantifying eukaryotic rRNA gene sequences from human microbiome samplesSerena Dollive, Gregory L Peterfreund, Scott Sherrill-Mix, et al.
The Oncologist|May 16, 2019
Anti-PD-1 Immunotherapy-Induced Flare of a Known Underlying Relapsing Vasculitis Mimicking Recurrent CancerChristopher S Nabel, Mariano Severgnini, Yin P Hung, et al.
NPJ Precision Oncology|June 26, 2026
Redefining therapeutic horizons in thymic epithelial tumors: precision, combinations, and emerging biologyJennifer A Marks, Rohan Maniar, Kavitha J Ramchandran, et al.
American Journal of Hematology|January 26, 2016
Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV-8-negative multicentric Castleman diseaseNoriko Iwaki, David C Fajgenbaum, Christopher S Nabel, et al.
Nature Immunology|May 12, 2025
Inhibition of ENT1 relieves intracellular adenosine-mediated T cell suppression in cancerTheodore J Sanders, Christopher S Nabel, Margreet Brouwer, et al.
Science Translational Medicine|November 8, 2019
Identification of DHODH as a therapeutic target in small cell lung cancerLeanne Li, Sheng Rong Ng, Caterina I Colón, et al.
Biorxiv : the Preprint Server for Biology|January 8, 2024
Metabolite profiling of human renal cell carcinoma reveals tissue-origin dominance in nutrient availabilityKeene L Abbott, Ahmed Ali, Bradley I Reinfeld, et al.
The Journal of Clinical Investigation|August 14, 2019
Identifying and targeting pathogenic PI3K/AKT/mTOR signaling in IL-6-blockade-refractory idiopathic multicentric Castleman diseaseDavid C Fajgenbaum, Ruth-Anne Langan, Alberto Sada Japp, et al.
Pageof 4